What is Arthromeda?
Arthromeda is at the forefront of orthopedic innovation, specializing in patient-specific solutions designed to enhance arthroplasty surgery. By integrating micro-sensors, wireless technologies, and custom software applications, the company aims to improve the precision of orthopedic implant alignment and fit in real-time. Their product suite, including the ArthroSight-PS micro-sensor platform for hip surgeries and ArthroPlan digital templating software, targets healthcare providers and orthopedic surgeons seeking advanced tools to reduce implant revision costs within the expanding joint replacement market.
How much funding has Arthromeda raised?
Arthromeda has raised a total of $3.2M across 1 funding round:
Debt
$3.2M
Debt (2025): $3.2M, investors not publicly disclosed
What's next for Arthromeda?
The recent major strategic investment positions Arthromeda for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and expand the company's commercial reach. With a focus on improving surgical precision and reducing healthcare costs, Arthromeda is poised to become a key player in the digital health and orthopedic technology sectors, driving innovation in joint replacement procedures.
See full Arthromeda company page
